Immunexpress Begins US Commercialization of Near-Patient Sepsis Diagnostic Test
The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.
United States United Kingdom Comunidad Autonoma De Cataluna Rollie Carlson Jorge Parada University Of Oxford
Source: genomeweb.com